Replies to post #430587 on Amarin Corp Plc (AMRN)

[Tatsumaki]

type 2 diabetes is a requirement for a prescription

From the article...

The NHS spending watchdog approved tirzepatide in June for diabetics and is expected to give it the green light for weight loss next month – at which point cardiologists will be able to prescribe it to most heart-failure patients.

T2D diagnosis wont be required if it's being prescribed under the weight loss indication once approved for national coverage in the UK. If you have the BMI, you'll qualify for a Rx. They can have side effects, but a lot people end up fighting to get their hands on these drugs on their own once they try them.

Pivotal trial findings were unveiled last night showing the drug, tirzepatide, cut the risk of death or worsening illness by more than a third – making it the first drug to have a significant impact on the most common form of the condition

Experts immediately hailed it a ‘new cornerstone of treatment’, adding that the jabs had the potential to reduce the number of heart failure hospital admissions by tens of thousands – saving vital NHS cash and easing the agony of patients and their families.

This absolutely will compete with V for NHS money in the CVD space.